Perrigo (PRGO) Receivables - Other (2015 - 2025)

Perrigo's (PRGO) quarterly Receivables - Other came in at -$98.0 million in Q1 2025, down 217.51% on a QoQ basis from $83.4 million in Q4 2021.

Perrigo (PRGO) Receivables - Other (2015 - 2025) Analysis & Trends

Perrigo (PRGO) has 3 years of Receivables - Other data on file, last reported at -$98.0 million in Q1 2025.

On a quarterly basis, Receivables - Other changed N/A year-over-year to -$98.0 million in Q1 2025; TTM through Oct 2021 was $83.4 million, a N/A change from a year earlier, with the FY2024 full-year figure at -$98.0 million, changed N/A from the prior year.
Receivables - Other for Q1 2025 stood at -$98.0 million, down from $83.4 million in the prior quarter.
Over the last five years, Receivables - Other for PRGO reached as high as $83.4 million in Q4 2021 and fell as low as -$98.0 million in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn
10	Perrigo	1.40 Bn	1.05 Bn	325.50 Mn

Download Data